Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Dr. Rajesh Jain has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers), Regulations, 1997 to BSE03-08-2011
Disclosures under Reg. 7(1) of SEBI (SAST) Regulations, 1997
Dr. Rajesh Jain has submitted the disclosure under Regulation 7(1) of SEBI (Substantial Acquisition of Shares & Takeovers), Regulations, 1997 to BSEDisclosures under Reg. 7(1A) of SEBI (SAST) Regulations, 1997
Soshil Kumar Jain has submitted the disclosure under Regulation 7(1A) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 1997 to BSE:Disclosures under Reg.13(4) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Soshil Kumar Jain has submitted the disclosure under Regulation 13(4) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSEFixes Book Closure for Dividend & AGM
Panacea Biotec Ltd has informed BSE that the Register of Members & Share Transfer Books of the Company will remain closed from September 21, 2011 to September 24, 2011 (both days inclusive) for the purpose of Payment of Dividend & 27th Annual General Meeting (AGM) of the Company to be held on September 24, 2011.The dividend shall be paid/dispatched on October 10, 2011.Financial Results for June 30, 2011
Panacea Biotec Ltd has informed BSE about the Financial Results for the period ended June 30, 2011.Panacea Biotec vows to protect millions of infants across the world from five infectious diseases
Panacea Biotec Ltd has informed BSE regarding a Press Release titled "Panacea Biotec vows to protect millions of infants across the world from five infectious diseases".Press Release :"Panacea Biotec, India's biggest vaccine manufacturer who introduced world's first fully liquid Pentavalent vaccine EasyFive in Jan., 2005 has pledged to support the cause of GAVI alliance by further reducing the cost of its Pentavalent Vaccine - EasyFive,...Disclosures under Reg.13(6) of SEBI (Prohibition of Insider Trading) Regulations, 1992
Panacea Biotec Ltd has submitted the disclosure under Regulation 13(6) of the SEBI (Prohibition of Insider Trading) Regulations, 1992 to BSE:Results Press Release
Panacea Biotec Ltd has informed BSE regarding a Press Release dated May 13, 2011 titled "Panacea Biotec reports impressive financial results for the Quarter & Year ended March 31, 2011".Board recommends Dividend
Panacea Biotec Ltd has informed BSE that the Board of Directors of the Company at its meeting held on May 13, 2011, inter alia, has recommended dividend of Re. 0.75 (75%) each on Equity Shares of the Company, for the financial year 2010-11. The total amount of dividend payable, if approved by Shareholders in their ensuing Annual General Meeting, shall be Rs. 45.9 million, excluding dividend distribution tax.Financial Results for Mar 31, 2011
Panacea Biotec Ltd has informed BSE about the Financial Results for the Period ended March 31, 2011.